Docs struggle with making MCI diagnoses, 2022 Alzheimer’s report finds
By
Alicia Lasek
Mar 23, 2022
Less than half of primary care physicians surveyed report being comfortable diagnosing mild cognitive impairment that’s due to Alzheimer’s disease. Fully 90% told researchers that it is “hard...
Slow buy-in: Only 3% of neurologists have written Aduhelm prescriptions so far
By
Alicia Lasek
Jul 15, 2021
Neurologists are very aware of Biogen’s newly approved Alzheimer’s drug, but few have prescribed it so far, a real-time study of the brand’s market launch has found.
FDA advisors to weigh use of Rexulti for Alzheimer’s agitation
By
Alicia Lasek
Apr 10, 2023
Expert advisors are set to determine whether Rexulti (brexpiprazole) is effective and safe for this new application, the FDA announced Monday.